Rc. Dickson et al., CLINICAL AND HISTOLOGIC PATTERNS OF EARLY GRAFT FAILURE DUE TO RECURRENT HEPATITIS-C IN 4 PATIENTS AFTER LIVER-TRANSPLANTATION, Transplantation, 61(5), 1996, pp. 701-705
Hepatitis C viral recurrence after orthotopic liver transplantation is
almost universal. Hepatitis C-induced graft failure may occur, but th
e clinical and histologic profiles are not well defined. The aim of th
is study was to describe the pattern of early graft failure in patient
s with recurrent hepatitis C after liver transplantation. Thirty patie
nts with hepatitis C underwent liver transplantation from October 1989
through September 1994, Four patients were excluded because of death
(2 patients), graft failure unrelated to hepatitis C (1 patient), and
lost to follow-up (1 patient), Hepatitis C recurred in 24 of the 26 re
maining patients, In 4 patients with hepatitis C virus recurrence and
cholestasis, graft failure developed at 5.25, 11.0, 11.0, and 18.5 mon
ths, The medical records and liver biopsies were reviewed. In all 4 pa
tients, a histologic pattern characterized by centrilobular ballooning
degeneration developed and progressed to involve more than two-thirds
of the lobules, Moderate to severe cholestasis and bridging fibrosis
were present in all grafts at explant. Two patients had portal inflamm
ation on 3-month biopsies consistent with viral hepatitis, AU patients
had mild macrovesicular steatosis, but only 1 patient had significant
lymphoid aggregates, No patient had evidence of hepatic artery thromb
osis, One patient had potential drug-induced cholestasis. One patient
had 3 episodes of rejection that were not believed to contribute to gr
aft loss, All 4 patients developed clinical features of hepatic failur
e and were retransplanted. Two patients had early recurrence of graft
failure. We conclude that a pattern of progressive centrilobular ballo
oning degeneration, bridging fibrosis, and cholestasis occurs in some
patients with hepatitis C with early graft failure, similar to fibrosi
ng cholestatic hepatitis seen in some transplant patients with recurre
nt hepatitis B.